Latest News

Data/Analytics Five big shifts in policy and technology that marketers should worry about in 2015

Five big shifts in policy and technology that marketers should worry about in 2015

"The trouble is that the market is changing much faster than most marketers realize."

Pharmaceutical Five things for pharma marketers to know: Friday, December 19

Five things for pharma marketers to know: Friday, December 19

Roche strikes out in cancer, Alzheimer's trials; Lilly in pact for fast-acting insulin; Humana revamps formulary.

Pharmaceutical Pfizer bets on Duchenne MD treatment

Pfizer bets on Duchenne MD treatment

The company moves on three leading contenders in the muscular dystrophy segment with the start of a Phase II trial

Legal/Regulatory OPDP slams print ad in Untitled Letter

OPDP slams print ad in Untitled Letter

The FDA's prescription drug promotion arm wrote that the professional print ad for seizure med Aptiom "misleadingly overstated its efficacy."

Pharmaceutical

Apotex challenges Amgen blockbuster Neulasta

Canadian firm presents FDA with its third biosimilar application.

Pharmaceutical

Merck buys Swiss biotech

The drugmaker announced it will acquire OncoEthix and its oncology candidate OTX015 in a deal worth up to $365 million

Pharmaceutical Five things for pharma marketers to know: Thursday, December 18

Five things for pharma marketers to know: Thursday, December 18

Shire may bid on NPS Pharmaceuticals; Amgen says cancer drug will cost $178,000; Takeda has a new head of R&D.

Pharmaceutical Pfizer urges parents to take the pledge against meningitis

Pfizer urges parents to take the pledge against meningitis

Pfizer has kicked off a disease-awareness campaign, "Take Action Against Meningitis," urging parents to discuss vaccinations with their healthcare providers with paralympic snowboarder Amy Purdy.

Pharmaceutical Court clears the way for Celebrex generics

Court clears the way for Celebrex generics

Ruling voids FDA's take on reissued patents, settling a year of challenges by generic applicants

Legal/Regulatory

FDA issues long-awaited plan for electronic labeling

The much hashed-over initiative would require pharma firms to distribute the professional insert electronically.


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.